全文获取类型
收费全文 | 1030644篇 |
免费 | 71145篇 |
国内免费 | 3939篇 |
专业分类
耳鼻咽喉 | 13882篇 |
儿科学 | 30627篇 |
妇产科学 | 26458篇 |
基础医学 | 155932篇 |
口腔科学 | 30256篇 |
临床医学 | 90110篇 |
内科学 | 200101篇 |
皮肤病学 | 23616篇 |
神经病学 | 73005篇 |
特种医学 | 37542篇 |
外国民族医学 | 157篇 |
外科学 | 156504篇 |
综合类 | 24109篇 |
现状与发展 | 3篇 |
一般理论 | 219篇 |
预防医学 | 66779篇 |
眼科学 | 24994篇 |
药学 | 80820篇 |
4篇 | |
中国医学 | 4357篇 |
肿瘤学 | 66253篇 |
出版年
2019年 | 7889篇 |
2018年 | 11852篇 |
2017年 | 9089篇 |
2016年 | 9955篇 |
2015年 | 11083篇 |
2014年 | 15323篇 |
2013年 | 21956篇 |
2012年 | 29384篇 |
2011年 | 30699篇 |
2010年 | 18232篇 |
2009年 | 17187篇 |
2008年 | 28265篇 |
2007年 | 30632篇 |
2006年 | 30827篇 |
2005年 | 28593篇 |
2004年 | 27681篇 |
2003年 | 26336篇 |
2002年 | 25544篇 |
2001年 | 59354篇 |
2000年 | 60487篇 |
1999年 | 49826篇 |
1998年 | 12348篇 |
1997年 | 10312篇 |
1996年 | 10196篇 |
1995年 | 9576篇 |
1994年 | 8727篇 |
1993年 | 8042篇 |
1992年 | 36407篇 |
1991年 | 35379篇 |
1990年 | 34240篇 |
1989年 | 33822篇 |
1988年 | 30604篇 |
1987年 | 29633篇 |
1986年 | 27904篇 |
1985年 | 26024篇 |
1984年 | 18602篇 |
1983年 | 15597篇 |
1982年 | 8284篇 |
1979年 | 16311篇 |
1978年 | 11112篇 |
1977年 | 9482篇 |
1976年 | 8591篇 |
1975年 | 9654篇 |
1974年 | 11296篇 |
1973年 | 10777篇 |
1972年 | 10246篇 |
1971年 | 9686篇 |
1970年 | 9226篇 |
1969年 | 8644篇 |
1968年 | 7879篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
Accurate diagnosis and recognition of predisposing factors has been shown to be challenging in lower limb cellulitis (LLC). Assessment of 1746 consecutive patients with cellulitis presenting to a UK university hospital showed increasing overdiagnosis, with only 31.9% of patients referred during the period 2015–2018 having the diagnosis of LLC confirmed. Recognition of at least one predisposing factor increased from 61% to 89% following introduction of more specific screening questions. This identified a need for better primary care dermatology education and the benefit of a proforma with specific screening questions for reversible predisposing factors for LLC. 相似文献
83.
Sania Amr Magdy Garas Dina N. K. Boulos Doa’a A. Saleh Irene A. Jillson Christopher A. Loffredo 《Journal of substance use》2019,24(3):341-345
Background: Egyptian street youth use substances including tobacco, illicit drugs, and pharmaceutical drugs. To understand the circumstances, including adverse childhood experiences, that place adolescents at risk for engaging in substance use, we conducted in-depth interviews among a sample of Egyptian street children. Methods: From youth residing at or attending Caritas, a non-profit organization, which provides shelter and education to street youth, seven girls and twelve boys, aged 12–18 years, participated in open-ended, in-depth interviews. Results: Eight out of the 19 participants reported family history (early exposure) to substance use; and seven of them were initiated by either a family member (sibling), friend or coworker. Most of the participants reported a history of conflict with or abuse (verbal or physical) by their parents or siblings, or stressful situations at home; they used substance(s) to alleviate their stress. Few attended school, and some were forced to work and help their family. Conclusions: Among Egyptian youth, adverse childhood experiences, such as poverty, child abuse, and family substance use, challenge somewhat susceptible youths and lead them to the path of substance use and addiction. Prevention intervention should be multifaceted, culturally adaptable, and primarily targeting the social environment during childhood. 相似文献
84.
85.
T.-Y. Huang Y.-J. Hsia M.-Y. Sung Y.-T. Wu P.-C. Hsu 《International journal of oral and maxillofacial surgery》2021,50(8):1100-1106
Zygomatic implant treatment is widely applied for severe maxillary atrophy to help rehabilitate the maxillary dentition. This retrospective study was performed to evaluate the actual radiographic bone–implant contact (rBIC) lengths of zygomatic implants. The records of 28 patients who underwent zygomatic implant surgery and subsequent follow-up examinations between August 2013 and September 2018 in the Department of Oral and Maxillofacial Surgery, Taipei Tzu Chi Hospital were reviewed. The surgeries were performed by a single surgeon using the same treatment protocol. All patients had a computed tomography scan at 1 year after the surgery. Using three-dimensional imaging software, an investigator measured the rBIC lengths of 66 implants and documented their clinical status. The implant survival rate was 100%. The mean rBIC length was significantly longer in male patients than in female patients (20.80 ± 5.88 mm versus 17.79 ± 6.34 mm; P = 0.028). The mean rBIC length of double zygomatic implants was significantly longer when compared to that of single implants (21.11 ± 6.23 mm versus 17.75 ± 5.85 mm; P = 0.027). This article is novel in reporting the exact rBIC lengths of zygomatic implants in a clinical setting. The results showed that zygomatic implants are a viable treatment modality for full-mouth rehabilitation. 相似文献
86.
87.
88.
In both adults and children with diabetes, technologies such as continuous subcutaneous insulin infusion using insulin pumps and continuous glucose monitoring can help improve diabetes control, reduce hypoglycaemia and improve quality of life. Access to these technologies in the UK is very variable. Some technologies are recommended by the National Institute for Health and Care Excellence, while others have not been appraised, and new technologies are emerging all the time. Additionally, different guidelines for adults and children further complicate access to diabetes technology in the transition from paediatric to adult care. Against this background, Diabetes UK and NHS England have brought together a multidisciplinary group of experts, including clinicians and people with diabetes, to develop this consensus guideline, combining the different technologies into a common pathway to aid clinical and policy decision‐making. We created a pathway that supports the incremental addition of technology as monotherapy and then dual therapy in the same way that we incrementally add in therapeutic agents to support people with Type 2 diabetes to achieve their personalized glycaemic targets. The pathway emphasizes the importance of structured education, specialist support and appropriate access to psychological therapies, as essential pillars for optimized use of diabetes‐related technology, and recommends the re‐evaluation of its use when the individual is unable either to use the technology appropriately or to achieve the intended outcomes. This pathway is endorsed by UK‐wide clinical and patient associations and we recommend that providers and commissioners use it to ensure the right individual with diabetes has access to the right technology in a timely way to help achieve better outcomes. 相似文献
89.
90.